Notice Information
Notice Title
GB-Salisbury: Pharma in vitro metabolism
Notice Description
NOTE: This notice was updated on 28 August 2016 for the following reason: Description of requirements changed to the following and requirement to be GLP compliant now removed as a pre-requisite to submitting an Expression of Interest Dstl is developing a number of active pharmaceutical ingredients (API) as medical countermeasures. In vitro metabolism studies of three API are required as the project moves forwards. These include determination of metabolism kinetics, metabolite identification, metabolising enzyme identification, blood:plasma ratio determination and identification of efflux transporters. All requirements will need suitably qualified analytical chemistry methods to quantify the concentrations of the API being studied. Suitable controls and appropriate factors to enable in vitro in vivo extrapolation (IVIVE) of the outputs from the work will also be required. The information/data required is in support of clinical development programmes with the API and therefore must be completed to satisfactory quality standards which must be adequately demonstrated.In vitro metabolism of the API being developed by Dstl and how this will be used to improve the understanding of the drugs as the project moves forwards to clinical trials. API must be completed to Good Laboratory Practice (GLP). Only Suppliers that have the mandatory GLP systems in place should express interest in this requirement. Additional information: To view this notice, register as a supplier here: http://www.contracts.mod.uk/delta/signup.html?userType=supplier and search for the notice with reference 'GB-Salisbury: Pharma in vitro metabolism'.
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-b5fd17-1b7c8112-adca-11e6-9901-0019b9f3037b
- Publication Source
- Contracts Finder
- Latest Notice
- https://www.contractsfinder.service.gov.uk/Notice/c933d2cb-9a05-48bf-96b2-eea6a799bafd
- Current Stage
- Tender
- All Stages
- Tender
Procurement Classification
- Notice Type
- Tender Notice
- Procurement Type
- Standard
- Procurement Category
- Services
- Procurement Method
- Open
- Procurement Method Details
- Open procedure
- Tender Suitability
- Not specified
- Awardee Scale
- Not specified
Common Procurement Vocabulary (CPV)
- CPV Divisions
33 - Medical equipments, pharmaceuticals and personal care products
38 - Laboratory, optical and precision equipments (excl. glasses)
-
- CPV Codes
33000000 - Medical equipments, pharmaceuticals and personal care products
33159000 - Clinical chemistry system
33600000 - Pharmaceutical products
38434560 - Chemistry analyser
Notice Value(s)
- Tender Value
- £113,000 £100K-£500K
- Lots Value
- Not specified
- Awards Value
- Not specified
- Contracts Value
- Not specified
Notice Dates
- Publication Date
- 18 Nov 20169 years ago
- Submission Deadline
- 30 Aug 2016Expired
- Future Notice Date
- Not specified
- Award Date
- Not specified
- Contract Period
- 29 Sep 2016 - 31 Mar 2017 6-12 months
- Recurrence
- Not specified
Notice Status
- Tender Status
- Active
- Lots Status
- Not Specified
- Awards Status
- Not Specified
- Contracts Status
- Not Specified
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- D BLACKMORE
- Contact Name
- Available with D3 Tenders Premium →
- Contact Email
- Available with D3 Tenders Premium →
- Contact Phone
- Available with D3 Tenders Premium →
Buyer Location
- Locality
- SALISBURY
- Postcode
- SP4 0JQ
- Post Town
- Salisbury
- Country
- England
-
- Major Region (ITL 1)
- TLK South West (England)
- Basic Region (ITL 2)
- TLK7 Gloucestershire and Wiltshire
- Small Region (ITL 3)
- TLK72 Wiltshire
- Delivery Location
- TLK South West (England)
-
- Local Authority
- Wiltshire
- Electoral Ward
- Winterslow & Upper Bourne Valley
- Westminster Constituency
- Salisbury
Further Information
Notice Documents
-
https://www.contractsfinder.service.gov.uk/Notice/c933d2cb-9a05-48bf-96b2-eea6a799bafd
28th August 2016 - Opportunity notice on Contracts Finder
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-b5fd17-1b7c8112-adca-11e6-9901-0019b9f3037b-2016-11-18T20:17:26Z",
"date": "2016-11-18T20:17:26Z",
"ocid": "ocds-b5fd17-1b7c8112-adca-11e6-9901-0019b9f3037b",
"language": "en",
"initiationType": "tender",
"tender": {
"id": "BIP46001046",
"title": "GB-Salisbury: Pharma in vitro metabolism",
"description": "NOTE: This notice was updated on 28 August 2016 for the following reason: Description of requirements changed to the following and requirement to be GLP compliant now removed as a pre-requisite to submitting an Expression of Interest Dstl is developing a number of active pharmaceutical ingredients (API) as medical countermeasures. In vitro metabolism studies of three API are required as the project moves forwards. These include determination of metabolism kinetics, metabolite identification, metabolising enzyme identification, blood:plasma ratio determination and identification of efflux transporters. All requirements will need suitably qualified analytical chemistry methods to quantify the concentrations of the API being studied. Suitable controls and appropriate factors to enable in vitro in vivo extrapolation (IVIVE) of the outputs from the work will also be required. The information/data required is in support of clinical development programmes with the API and therefore must be completed to satisfactory quality standards which must be adequately demonstrated.In vitro metabolism of the API being developed by Dstl and how this will be used to improve the understanding of the drugs as the project moves forwards to clinical trials. API must be completed to Good Laboratory Practice (GLP). Only Suppliers that have the mandatory GLP systems in place should express interest in this requirement. Additional information: To view this notice, register as a supplier here: http://www.contracts.mod.uk/delta/signup.html?userType=supplier and search for the notice with reference 'GB-Salisbury: Pharma in vitro metabolism'.",
"datePublished": "2016-08-28T07:54:04+01:00",
"status": "active",
"classification": {
"scheme": "CPV",
"id": "38434560",
"description": "Chemistry analyser"
},
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33000000",
"description": "Medical equipments, pharmaceuticals and personal care products"
},
{
"scheme": "CPV",
"id": "33159000",
"description": "Clinical chemistry system"
},
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"items": [
{
"id": "1",
"deliveryAddresses": [
{
"region": "South West",
"countryName": "United Kingdom"
}
]
}
],
"minValue": {
"amount": 10000,
"currency": "GBP"
},
"value": {
"amount": 113000,
"currency": "GBP"
},
"procurementMethod": "open",
"procurementMethodDetails": "Open procedure",
"tenderPeriod": {
"endDate": "2016-08-30T23:59:59+01:00"
},
"contractPeriod": {
"startDate": "2016-09-30T00:00:00+01:00",
"endDate": "2017-03-31T23:59:59+01:00"
},
"suitability": {
"sme": false,
"vcse": false
},
"mainProcurementCategory": "services",
"documents": [
{
"id": "1",
"documentType": "tenderNotice",
"description": "Opportunity notice on Contracts Finder",
"url": "https://www.contractsfinder.service.gov.uk/Notice/c933d2cb-9a05-48bf-96b2-eea6a799bafd",
"datePublished": "2016-08-28T07:54:04+01:00",
"format": "text/html",
"language": "en"
}
]
},
"parties": [
{
"id": "GB-CFS-33796",
"name": "D Blackmore",
"identifier": {
"legalName": "D Blackmore"
},
"address": {
"streetAddress": "Commercial Services, Building 5",
"locality": "Salisbury",
"postalCode": "SP4 0JQ",
"countryName": "UK"
},
"contactPoint": {
"name": "D Blackmore",
"email": "dblackmore@dstl.gov.uk",
"telephone": "+441980955431"
},
"roles": [
"buyer"
]
}
],
"buyer": {
"id": "GB-CFS-33796",
"name": "D Blackmore"
}
}